Cargando…

Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems

Among modern drug formulations, stimuli-responsive hydrogels also called “smart hydrogels” deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by vario...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasiński, Adam, Zielińska-Pisklak, Monika, Oledzka, Ewa, Sobczak, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326401/
https://www.ncbi.nlm.nih.gov/pubmed/32617004
http://dx.doi.org/10.2147/IJN.S248987
_version_ 1783552334241988608
author Kasiński, Adam
Zielińska-Pisklak, Monika
Oledzka, Ewa
Sobczak, Marcin
author_facet Kasiński, Adam
Zielińska-Pisklak, Monika
Oledzka, Ewa
Sobczak, Marcin
author_sort Kasiński, Adam
collection PubMed
description Among modern drug formulations, stimuli-responsive hydrogels also called “smart hydrogels” deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by various stimuli, such as temperature, pH, electromagnetic radiation, magnetic field and biological factors. Therefore, stimuli-responsive matrices can be potentially used in tissue engineering, cell cultures and technology of innovative drug delivery systems (DDSs), releasing the active substances under the control of internal or external stimuli. Moreover, smart hydrogels can be used as injectable DDSs, due to gel–sol transition connected with in situ cross-linking process. Innovative smart hydrogel DDSs can be utilized as matrices for targeted therapy, which enhances the effectiveness of tumor chemotherapy and subsequently limits systemic toxicity. External stimulus sensitivity allows remote control over the drug release profile and gel formation. On the other hand, internal factors provide drg accumulation in tumor tissue and reduce the concentration of active drug form in healthy tissue. In this report, we summarise the basic knowledge and chemical strategies for the synthetic smart hydrogel DDSs applied in antitumor therapy.
format Online
Article
Text
id pubmed-7326401
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73264012020-07-01 Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems Kasiński, Adam Zielińska-Pisklak, Monika Oledzka, Ewa Sobczak, Marcin Int J Nanomedicine Review Among modern drug formulations, stimuli-responsive hydrogels also called “smart hydrogels” deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by various stimuli, such as temperature, pH, electromagnetic radiation, magnetic field and biological factors. Therefore, stimuli-responsive matrices can be potentially used in tissue engineering, cell cultures and technology of innovative drug delivery systems (DDSs), releasing the active substances under the control of internal or external stimuli. Moreover, smart hydrogels can be used as injectable DDSs, due to gel–sol transition connected with in situ cross-linking process. Innovative smart hydrogel DDSs can be utilized as matrices for targeted therapy, which enhances the effectiveness of tumor chemotherapy and subsequently limits systemic toxicity. External stimulus sensitivity allows remote control over the drug release profile and gel formation. On the other hand, internal factors provide drg accumulation in tumor tissue and reduce the concentration of active drug form in healthy tissue. In this report, we summarise the basic knowledge and chemical strategies for the synthetic smart hydrogel DDSs applied in antitumor therapy. Dove 2020-06-25 /pmc/articles/PMC7326401/ /pubmed/32617004 http://dx.doi.org/10.2147/IJN.S248987 Text en © 2020 Kasiński et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Kasiński, Adam
Zielińska-Pisklak, Monika
Oledzka, Ewa
Sobczak, Marcin
Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
title Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
title_full Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
title_fullStr Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
title_full_unstemmed Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
title_short Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
title_sort smart hydrogels – synthetic stimuli-responsive antitumor drug release systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326401/
https://www.ncbi.nlm.nih.gov/pubmed/32617004
http://dx.doi.org/10.2147/IJN.S248987
work_keys_str_mv AT kasinskiadam smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems
AT zielinskapisklakmonika smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems
AT oledzkaewa smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems
AT sobczakmarcin smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems